메뉴 건너뛰기
Journal of the Canadian Urological Association
Volumn 9, Issue 3-4APRIL, 2015, Pages E193-E199
A hospital-based study of initial observation for low-risk prostate cancer and its predictors in the United States
Author keywords

Active surveillance; Observation; Prostatic neoplasms; Trends; Utilization; Watchful waiting
Indexed keywords

EID: 84928031314     PISSN: 19116470     EISSN: 19116470     Source Type: Journal    
DOI: 10.5489/cuaj.2606     Document Type: Article
Times cited : (5)
References (33)
  • 1
    • 84863961968 scopus 로고    scopus 로고
    • Screening for prostate cancer: U.S. Preventive services task force recommendation statement
    • Moyer VA, U.S. Preventive Services Task Force. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012;157:120-34. http://dx.doi.org/10.7326/0003-4819-157-2-201207170-00459
    • (2012) Ann Intern Med , vol.157 , pp. 120-134
    • Moyer, V.A.1
  • 2
    • 84919871373 scopus 로고    scopus 로고
    • Screening and prostate cancer mortality: Results of the european randomised study of screening for prostate cancer (erspc) at 13 years of follow-up
    • Epub 2014 Aug 6
    • Schroder FH, Hugosson J, Roobol MJ, et al. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet 2014;384:2027-35. http://dx.doi.org/10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.
    • (2014) Lancet , vol.384 , pp. 2027-2035
    • Schroder, F.H.1    Hugosson, J.2    Roobol, M.J.3
  • 3
    • 77955279420 scopus 로고    scopus 로고
    • Mortality results from the goteborg randomised population-based prostate-cancer screening trial
    • Hugosson J, Carlsson S, Aus G, et al. Mortality results from the Goteborg randomised population-based prostate-cancer screening trial. Lancet Oncol 2010;11:725-32. http://dx.doi.org/10.1016/S14702045(10)70146-7
    • (2010) Lancet Oncol , vol.11 , pp. 725-732
    • Hugosson, J.1    Carlsson, S.2    Aus, G.3
  • 4
    • 64949135826 scopus 로고    scopus 로고
    • Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context
    • Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: Importance of methods and context. J Natl Cancer Inst 2009;101:374-83. http://dx.doi.org/10.1093/jnci/djp001
    • (2009) J Natl Cancer Inst , vol.101 , pp. 374-383
    • Draisma, G.1    Etzioni, R.2    Tsodikov, A.3
  • 6
    • 84873050980 scopus 로고    scopus 로고
    • Long-term functional outcomes after treatment for localized prostate cancer
    • Resnick MJ, Koyama T, Fan KH, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 2013;368:436-45. http://dx.doi.org/10.1056/NEJMoa1209978
    • (2013) N Engl J Med , vol.368 , pp. 436-445
    • Resnick, M.J.1    Koyama, T.2    Fan, K.H.3
  • 7
    • 85006511607 scopus 로고    scopus 로고
    • Expected population impacts of discontinued prostate-specific antigen screening
    • Gulati R, Tsodikov A, Etzioni R, et al. Expected population impacts of discontinued prostate-specific antigen screening. Cancer 2014;120:3519-26. http://dx.doi.org/10.1002/cncr.28932
    • (2014) Cancer , vol.120 , pp. 3519-3526
    • Gulati, R.1    Tsodikov, A.2    Etzioni, R.3
  • 8
    • 84864008031 scopus 로고    scopus 로고
    • Radical prostatectomy versus observation for localized prostate cancer
    • Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367:203-13. http://dx.doi.org/10.1056/NEJMoa1113162
    • (2012) N Engl J Med , vol.367 , pp. 203-213
    • Wilt, T.J.1    Brawer, M.K.2    Jones, K.M.3
  • 9
    • 73949130115 scopus 로고    scopus 로고
    • Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
    • Klotz L, Zhang L, Lam A, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol 2010;28:126-31. http://dx.doi.org/10.1200/JCO.2009.24.2180
    • (2010) J Clin Oncol , vol.28 , pp. 126-131
    • Klotz, L.1    Zhang, L.2    Lam, A.3
  • 10
    • 84870898032 scopus 로고    scopus 로고
    • Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer
    • Bul M, van den Bergh RC, Zhu X, et al. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer. BJU Int 2012;110:1672-7. http://dx.doi.org/10.1111/j.1464-410X.2012.11434.x
    • (2012) BJU Int , vol.110 , pp. 1672-1677
    • Bul, M.1    Van Den Bergh, R.C.2    Zhu, X.3
  • 11
    • 84870506614 scopus 로고    scopus 로고
    • Outcome following active surveillance of men with screendetected prostate cancer. Results from the goteborg randomised population-based prostate cancer screening trial
    • Godtman RA, Holmberg E, Khatami A, et al. Outcome following active surveillance of men with screendetected prostate cancer. Results from the Goteborg randomised population-based prostate cancer screening trial. Eur Urol 2013;63:101-7. http://dx.doi.org/10.1016/j.eururo.2012.08.066
    • (2013) Eur Urol , vol.63 , pp. 101-107
    • Godtman, R.A.1    Holmberg, E.2    Khatami, A.3
  • 12
    • 84861231403 scopus 로고    scopus 로고
    • Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance
    • Davison BJ, Breckon E. Factors influencing treatment decision making and information preferences of prostate cancer patients on active surveillance. Patient Educ Couns 2012;87:369-74. http://dx.doi.org/10.1016/j.pec.2011.11.009
    • (2012) Patient Educ Couns , vol.87 , pp. 369-374
    • Davison, B.J.1    Breckon, E.2
  • 13
    • 2942677245 scopus 로고    scopus 로고
    • The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management
    • Cooperberg MR, Lubeck DP, Meng MV, et al. The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management. J Clin Oncol 2004;22:2141-9. http://dx.doi.org/10.1200/JCO.2004.10.062
    • (2004) J Clin Oncol , vol.22 , pp. 2141-2149
    • Cooperberg, M.R.1    Lubeck, D.P.2    Meng, M.V.3
  • 14
    • 12144289009 scopus 로고    scopus 로고
    • Watchful waiting and factors predictive of secondary treatment of localized prostate cancer
    • Wu H, Sun L, Moul JW, et al. Watchful waiting and factors predictive of secondary treatment of localized prostate cancer. J Urol 2004;171:1111-6. http://dx.doi.org/10.1097/01.ju.0000113300.74132.8b
    • (2004) J Urol , vol.171 , pp. 1111-1116
    • Wu, H.1    Sun, L.2    Moul, J.W.3
  • 15
    • 0036130518 scopus 로고    scopus 로고
    • Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression
    • Choo R, Klotz L, Danjoux C, et al. Feasibility study: Watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression. J Urol 2002;167:1664-9. http://dx.doi.org/10.1016/S00225347(05)65174-9
    • (2002) J Urol , vol.167 , pp. 1664-1669
    • Choo, R.1    Klotz, L.2    Danjoux, C.3
  • 16
    • 84888639235 scopus 로고    scopus 로고
    • Population-based study of utilization and determinants of active surveillance and watchful waiting for low- and intermediate-risk prostate cancer
    • Loeb S, Berglund A, Stattin P. Population-based study of utilization and determinants of active surveillance and watchful waiting for low- and intermediate-risk prostate cancer. J Urol 2013;190:1742-9. http://dx.doi.org/10.1016/j.juro.2013.05.054
    • (2013) J Urol , vol.190 , pp. 1742-1749
    • Loeb, S.1    Berglund, A.2    Stattin, P.3
  • 17
    • 0030918075 scopus 로고    scopus 로고
    • A comparison of breast, colorectal, lung, and prostate cancers reported to the national cancer data base and the surveillance, epidemiology, and end results program
    • Mettlin CJ, Menck HR, Winchester DP, et al. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer 1997;79:2052-61. http://dx.doi.org/10.1002/(SICI)10970142(19970515)79:10<2052::AID-CNCR29>3.0.CO;2-S
    • (1997) Cancer , vol.79 , pp. 2052-2061
    • Mettlin, C.J.1    Menck, H.R.2    Winchester, D.P.3
  • 18
    • 84928039326 scopus 로고    scopus 로고
    • Accessed April 13, 2015
    • United States Department of Agriculture Economic Research Service; 2003. http://www.ers.usda.gov/data-products/rural-urban-continuum-codes. Accessed April 13, 2015.
    • (2003)
  • 19
    • 34248175743 scopus 로고    scopus 로고
    • Guideline for the management of clinically localized prostate cancer: 2007 update
    • Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2012;177:2106-31. http://dx.doi.org/10.1016/j.juro.2007.03.003
    • (2012) J Urol , vol.177 , pp. 2106-2131
    • Thompson, I.1    Thrasher, J.B.2    Aus, G.3
  • 20
    • 84862877628 scopus 로고    scopus 로고
    • Individualized estimation of the benefit of radical prostatectomy from the scandinavian prostate cancer group randomized trial
    • Vickers A, Bennette C, Steineck G, et al. Individualized estimation of the benefit of radical prostatectomy from the Scandinavian Prostate Cancer Group randomized trial. Eur Urol 2012;62:204-9. http://dx.doi.org/10.1016/j.eururo.2012.04.024
    • (2012) Eur Urol , vol.62 , pp. 204-209
    • Vickers, A.1    Bennette, C.2    Steineck, G.3
  • 21
    • 84912569792 scopus 로고    scopus 로고
    • Variation in treatment associated with life expectancy in a populationbased cohort of men with early-stage prostate cancer
    • Daskivich TJ, Lai J, Dick AW, et al. Variation in treatment associated with life expectancy in a populationbased cohort of men with early-stage prostate cancer. Cancer 2014;120:3642-50. http://dx.doi.org/10.1002/cncr.28926
    • (2014) Cancer , vol.120 , pp. 3642-3650
    • Daskivich, T.J.1    Lai, J.2    Dick, A.W.3
  • 22
    • 77949898163 scopus 로고    scopus 로고
    • Time trends and local variation in primary treatment of localized prostate cancer
    • Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010;28:1117-23. http://dx.doi.org/10.1200/JCO.2009.26.0133
    • (2010) J Clin Oncol , vol.28 , pp. 1117-1123
    • Cooperberg, M.R.1    Broering, J.M.2    Carroll, P.R.3
  • 23
    • 84922619184 scopus 로고    scopus 로고
    • Increasing use of observation among men at low risk for prostate cancer mortality
    • Epub 2014 Sep 6
    • Ritch CR, Graves AJ, Keegan KA, et al. Increasing use of observation among men at low risk for prostate cancer mortality. J Urol 2015;193:801-6. http://dx.doi.org/10.1016/j.juro.2014.08.102. Epub 2014 Sep 6.
    • (2015) J Urol , vol.193 , pp. 801-806
    • Ritch, C.R.1    Graves, A.J.2    Keegan, K.A.3
  • 24
    • 51149102477 scopus 로고    scopus 로고
    • What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the capsure database
    • Barocas DA, Cowan JE, Smith JA, Jr, et al. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database. J Urol 2008;180:13305. http://dx.doi.org/10.1016/j.juro.2008.06.019
    • (2008) J Urol , vol.180 , pp. 1330-1335
    • Barocas, D.A.1    Cowan, J.E.2    Smith, J.A.3
  • 25
    • 77749286517 scopus 로고    scopus 로고
    • Short-term outcomes of the prospective multicentre ‘prostate cancer research international: Active surveillance’ study
    • van den Bergh RC, Vasarainen H, van der Poel HG, et al. Short-term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’ study. BJU Int 2010;105:956-62. http://dx.doi.org/10.1111/j.1464-410X.2009.08887.x
    • (2010) BJU Int , vol.105 , pp. 956-962
    • Van Den Bergh, R.C.1    Vasarainen, H.2    Van Der Poel, H.G.3
  • 26
    • 1642305564 scopus 로고    scopus 로고
    • Racial/ethnic disparities in the treatment of localized/regional prostate cancer
    • Underwood W, De Monner S, Ubel P, et al. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 2004;171:1504-7. http://dx.doi.org/10.1097/01.ju.0000118907.64125.e0
    • (2004) J Urol , vol.171 , pp. 1504-1507
    • Underwood, W.1    De Monner, S.2    Ubel, P.3
  • 27
    • 77950933240 scopus 로고    scopus 로고
    • Factors associated with initial treatment and survival for clinically localized prostate cancer: Results from the cdc-npcr patterns of care study (poc1)
    • Schymura MJ, Kahn AR, German RR, et al. Factors associated with initial treatment and survival for clinically localized prostate cancer: Results from the CDC-NPCR Patterns of Care Study (PoC1). BMC Cancer 2010;10:1-15. http://dx.doi.org/10.1186/1471-2407-10-152
    • (2010) BMC Cancer , vol.10 , pp. 1-15
    • Schymura, M.J.1    Kahn, A.R.2    German, R.R.3
  • 28
    • 84875373168 scopus 로고    scopus 로고
    • The impact of socioeconomic status on prostate cancer treatment and survival in the southern netherlands
    • Aarts MJ, Koldewijn EL, Poortmans PM, et al. The impact of socioeconomic status on prostate cancer treatment and survival in the southern Netherlands. Urology 2013;81:593-9. http://dx.doi.org/10.1016/j.urology.2012.11.011
    • (2013) Urology , vol.81 , pp. 593-599
    • Aarts, M.J.1    Koldewijn, E.L.2    Poortmans, P.M.3
  • 29
    • 84895067191 scopus 로고    scopus 로고
    • Active surveillance for low-risk prostate cancer in african american men: A multi-institutional experience
    • Odom BD, Mir MC, Hughes S, et al. Active surveillance for low-risk prostate cancer in African American men: A multi-institutional experience. Urology 2014;83:364-8. http://dx.doi.org/10.1016/j.urology.2013.09.038
    • (2014) Urology , vol.83 , pp. 364-368
    • Odom, B.D.1    Mir, M.C.2    Hughes, S.3
  • 30
    • 79956354609 scopus 로고    scopus 로고
    • Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer
    • Corcoran AT, Peele PB, Benoit RM. Cost comparison between watchful waiting with active surveillance and active treatment of clinically localized prostate cancer. Urology 2010;76:703-7. http://dx.doi.org/10.1016/j.urology.2009.12.071
    • (2010) Urology , vol.76 , pp. 703-707
    • Corcoran, A.T.1    Peele, P.B.2    Benoit, R.M.3
  • 31
    • 84912529323 scopus 로고    scopus 로고
    • American trends in expectant management utilization for prostate cancer from 2000-2009
    • Maurice MJ, Abouassaly R, Zhu H. American trends in expectant management utilization for prostate cancer from 2000-2009. Can Urol Assoc J 2014;8:E775-82. http://dx.doi.org/10.5489/cuaj.2073
    • (2014) Can Urol Assoc J , vol.8 , pp. E775-E782
    • Maurice, M.J.1    Abouassaly, R.2    Zhu, H.3
  • 32
    • 79952359225 scopus 로고    scopus 로고
    • That influence patient enrollment in active surveillance for low-risk prostate cancer
    • Gorin MA, Soloway CT, Eldefrawy A. Factors that influence patient enrollment in active surveillance for low-risk prostate cancer. Urology 2011;77:588-91. http://dx.doi.org/10.1016/j.urology.2010.10.039
    • (2011) Urology , vol.77 , pp. 588-591
    • Gorin, M.A.1    Soloway, C.T.2    Factors, E.A.3
  • 33
    • 84906330343 scopus 로고    scopus 로고
    • Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: Baseline results from a shared decision-making trial
    • Kaplan AL, Crespi CM, Saucedo JD, et al. Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: Baseline results from a shared decision-making trial. Cancer 2014;120:2721-7. http://dx.doi.org/10.1002/cncr.28755
    • (2014) Cancer , vol.120 , pp. 2721-2727
    • Kaplan, A.L.1    Crespi, C.M.2    Saucedo, J.D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.